Pharma group plans plant in North Carolina to produce diabetes drug and weight-loss product Wegovy
Vous n'êtes pas connecté
The scramble for semaglutide-containing injectables as an aid to weight loss means manufacturers are prioritising them over insulin pens.
Pharma group plans plant in North Carolina to produce diabetes drug and weight-loss product Wegovy
WEDNESDAY, July 3, 2024 -- Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study...
Can spending time in a sauna aid weight loss and improve insulin sensitivity in older women? Yes, it may reduce age-related obesity and insulin...
Médecins sans frontières (MSF) or Doctors Without Borders, is an international humanitarian-aid non-governmental organization (NGO) and Nobel Peace...
THURSDAY, June 27, 2024 -- For adults with obesity, without diabetes, combining exercise with the glucagon-like peptide-1 receptor agonist (GLP-1 RA),...
Maxwell Adeyemi MANY WOMEN are quite shocked and frustrated when they begin to notice those extra pounds as they approach or reach menopause. They...
CNN — People who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. Still, doctors say...
One of the world’s foremost humanitarian organizations, Medicines Sans Frontieres (MSF), also known as Doctors Without Borders, can work effectively...
The hype is enormous: A new weight-loss drug is being aggressively marketed on social media – promising patients a quick fix for obesity. But...
TUESDAY, June 25, 2024 -- A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye...